ProBiotix Health signs agreement to cover Australian and New Zealand probiotics market

The life sciences business ProBiotix Health has signed an exclusive distribution agreement with Trans Chem to cover the Australian and New Zealand probiotics market.

Trans Chem is one of Australia’s largest independent suppliers of products and ingredients for the pharmaceutical, nutraceutical, food and beverage, veterinary and animal nutrition industries. Trans Chem’s operations extend across Australia and New Zealand.

In a statement, ProBiotix Health said: “Trans Chem’s customers include all the major leading pharma and nutraceutical brand owners in the region and the numerous contract manufacturers who service and support these players. They also have a strong emerging international food and beverage business.”

Hide Ad
Hide Ad

Steen Andersen, the CEO of ProBiotix Health plc commented: “We are delighted to have signed this agreement with Trans Chem, which will further enhance our global reach.

ProBiotix Health has signed an exclusive distribution agreement with Trans Chem to cover the Australian and New Zealand probiotics market. (Photo of stock exchange from PA)ProBiotix Health has signed an exclusive distribution agreement with Trans Chem to cover the Australian and New Zealand probiotics market. (Photo of stock exchange from PA)
ProBiotix Health has signed an exclusive distribution agreement with Trans Chem to cover the Australian and New Zealand probiotics market. (Photo of stock exchange from PA)

"Although our primary strategic focus is on developing the European and North American markets, we believe that there is a significant business potential in Australia and New Zealand. Both countries have a high concentration of dietary supplement companies acting as a gateway into servicing mainland China and the Southeast Asian region, which we can now capitalise on. Trans Chem is a leading distributor in the region.”